Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Cer 18:2;O/24:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004300 AN007152 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Brain Mouse Liver disease University of Louisville LC-MS
ST004300 AN007152 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Liver Mouse Liver disease University of Louisville LC-MS
ST004300 AN007154 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Brain Mouse Liver disease University of Louisville LC-MS
ST004300 AN007154 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Liver Mouse Liver disease University of Louisville LC-MS
ST003664 AN006020 Tumour interstitial fluid-enriched phosphoethanolamine suppresses T cell function. T-cells Mouse Cancer University of Chicago LC-MS
ST003364 AN005511 Deep lipidomic profiling reveals sex dimorphism of lipid metabolism in fibro-calcific aortic valve disease Aortic valve tissue Human Heart disease Technical University Dresden LC-MS
ST002956 AN004853 An application of automated LLE extraction in determine the age and HFD effects in adult mice in metabolomic, lipidomic, and proteomic Blood Mouse Calico Life Sciences LC-MS
  logo